High-Sensitivity C-Reactive Protein Leads to Increased Incident Metabolic Syndrome in Women but Not in Men: A Five-Year Follow-Up Study in a Chinese Population

References

• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z
   PubMed Web of Science ®Google Scholar
• Zafar U, Khaliq S, Ahmad HU, Manzoor S, Lone KP. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links. Hormones (Athens). 2018;17(3):299–313. doi:10.1007/s42000-018-0051-3
   PubMedGoogle Scholar
• Lu J, Wang L, Li M, et al. Metabolic syndrome among adults in China: the 2010 China noncommunicable disease surveillance. J Clin Endocrinol Metab. 2017;102(2):507–515. doi:10.1210/jc.2016-2477
   PubMed Web of Science ®Google Scholar
• Povel CM, Beulens JW, van der Schouw YT, et al. Metabolic syndrome model definitions predicting Type 2 diabetes and cardiovascular disease. Diabetes Care. 2013;36(2):362–368. doi:10.2337/dc11-2546
   PubMedGoogle Scholar
• de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008;54(6):945–955. doi:10.1373/clinchem.2007.100156
   PubMed Web of Science ®Google Scholar
• Luan -Y-Y, Yao Y-M. The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Front Immunol. 2018;9:1302. doi:10.3389/fimmu.2018.01302
   PubMed Web of Science ®Google Scholar
• Song Y, Yang SK, Kim J, Lee DC. Association between C-reactive protein and metabolic syndrome in Korean adults. Korean J Fam Med. 2019;40(2):116–123. doi:10.4082/kjfm.17.0075
   PubMed Web of Science ®Google Scholar
• Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000;23(12):1835–1839. doi:10.2337/diacare.23.12.1835
   PubMed Web of Science ®Google Scholar
• Suhett LG, Hermsdorff HHM, Rocha NP, et al. Increased C-reactive protein in Brazilian children: association with cardiometabolic risk and metabolic syndrome components (PASE study). Cardiol Res Pract. 2019;2019:3904568. doi:10.1155/2019/3904568
   PubMedGoogle Scholar
• Mirhafez SR, Ebrahimi M, Saberi Karimian M, et al. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects. Eur J Clin Nutr. 2016;70(11):1298–1304. doi:10.1038/ejcn.2016.111
   PubMed Web of Science ®Google Scholar
• Mazidi M, Toth PP, Banach M. C-reactive protein is associated with prevalence of the metabolic syndrome, hypertension, and diabetes mellitus in US adults. Angiology. 2018;69(5):438–442. doi:10.1177/0003319717729288
   PubMed Web of Science ®Google Scholar
• Mahajan A, Jaiswal A, Tabassum R, et al. Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians. Atherosclerosis. 2012;220(1):275–281. doi:10.1016/j.atherosclerosis.2011.10.031
   PubMedGoogle Scholar
• Hillman AJ, Lohsoonthorn V, Hanvivatvong O, Jiamjarasrangsi W, Lertmaharit S, Williams MA. Association of high sensitivity C-reactive protein concentrations and metabolic syndrome among Thai adults. Asian Biomed. 2010;4(3):385–393. doi:10.2478/abm-2010-0047
   Google Scholar
• Ridker P, Buring J, Cook N, Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391–397. doi:10.1161/01.CIR.0000055014.62083.05
   PubMed Web of Science ®Google Scholar
• Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr., Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation. 2004;110(4):380–385. doi:10.1161/01.CIR.0000136581.59584.0E
   PubMed Web of Science ®Google Scholar
• Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of Type 2 diabetes. A systematic review and meta-analysis. Diabetes Care. 2013;36(1):166–175.
   PubMed Web of Science ®Google Scholar
• Kanmani S, Kwon M, Shin M-K, Kim MK. Association of C-reactive protein with risk of developing Type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study. Sci Rep. 2019;9(1):4573. doi:10.1038/s41598-019-40987-8
   PubMedGoogle Scholar
• Pan A, Wang Y, Yuan J-M, Koh W-P. High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese health study. BMC Endocr Disord. 2017;17(1):8. doi:10.1186/s12902-017-0159-5
   PubMedGoogle Scholar
• Morimoto H, Sakata K, Oishi M, et al. Effect of high-sensitivity C-reactive protein on the development of diabetes as demonstrated by pooled logistic-regression analysis of annual health-screening information from male Japanese workers. Diabetes Metab. 2013;39(1):27–33. doi:10.1016/j.diabet.2012.03.004
   PubMedGoogle Scholar
• Chiu F-H, Chuang CH, Li W-C, et al. The association of leptin and C-reactive protein with the cardiovascular risk factors and metabolic syndrome score in Taiwanese adults. Cardiovasc Diabetol. 2012;11:40. doi:10.1186/1475-2840-11-40
   PubMed Web of Science ®Google Scholar
• Torres JL, Ridker PM. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol. 2003;18(6):471–478. doi:10.1097/00001573-200311000-00008
   PubMedGoogle Scholar
• Laaksonen DE, Niskanen L, Nyyssonen K, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47(8):1403–1410. doi:10.1007/s00125-004-1472-x
   PubMed Web of Science ®Google Scholar
• Hassinen M, Lakka TA, Komulainen P, Gylling H, Nissinen A, Rauramaa R. C-reactive protein and metabolic syndrome in elderly women: a 12-year follow-up study. Diabetes Care. 2006;29(4):931–932. doi:10.2337/diacare.29.04.06.dc05-2508
   PubMedGoogle Scholar
• Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 2002;25(11):2016–2021. doi:10.2337/diacare.25.11.2016
   PubMed Web of Science ®Google Scholar
• Yoon K, Ryu S, Lee J, Park JD. Higher and increased concentration of hs-CRP within normal range can predict the incidence of metabolic syndrome in healthy men. Diabetes Metab Syndr. 2018;12(6):977–983. doi:10.1016/j.dsx.2018.06.008
   PubMedGoogle Scholar
• Oda E, Kawai R. Tentative cut point of high-sensitivity C-reactive protein for a component of metabolic syndrome in Japanese. Circ J. 2009;73(4):755–759. doi:10.1253/circj.CJ-08-0848
   PubMedGoogle Scholar
• Lai MM, Li CI, Kardia SL, et al. Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population. BMC Public Health. 2010;10:429. doi:10.1186/1471-2458-10-429
   PubMed Web of Science ®Google Scholar
• Garcia VP, Rocha HN, Sales AR, Rocha NG, da Nobrega AC. Sex differences in high sensitivity C-reactive protein in subjects with risk factors of metabolic syndrome. Arq Bras Cardiol. 2016;106(3):182–187. doi:10.5935/abc.20160027
   PubMedGoogle Scholar
• Wen J, Liang Y, Wang F, et al. Association of C-reactive protein and metabolic syndrome in a rural Chinese population. Clin Biochem. 2009;42(10–11):976–983. doi:10.1016/j.clinbiochem.2009.03.026
   PubMedGoogle Scholar
• Zhang L, Chen S, Deng A, et al. Association between lipid ratios and insulin resistance in a Chinese population. PLoS One. 2015;10(1):e0116110. doi:10.1371/journal.pone.0116110
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou C, Shao X, et al. Hypertriglyceridemic waist phenotype and chronic kidney disease in a Chinese population aged 40 years and older. PLoS One. 2014;9(3):e92322. doi:10.1371/journal.pone.0092322
   PubMed Web of Science ®Google Scholar
• Li Y, Chen Y, Liu X, et al. Metabolic syndrome and chronic kidney disease in a Southern Chinese population. Nephrology. 2014;19(6):325–331. doi:10.1111/nep.2014.19.issue-6
   PubMedGoogle Scholar
• Chen S, Liu H, Liu X, et al. Central obesity, C-reactive protein and chronic kidney disease: a community-based cross-sectional study in southern China. Kidney Blood Press Res. 2013;37(4–5):392–401. doi:10.1159/000355718
   PubMed Web of Science ®Google Scholar
• Chen S, Chen Y, Liu X, et al. Insulin resistance and metabolic syndrome in normal-weight individuals. Endocrine. 2014;46(3):496–504. doi:10.1007/s12020-013-0079-8
   PubMed Web of Science ®Google Scholar
• Chen S, Chen Y, Liu X, et al. Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight. PLoS One. 2013;8(9):e74058. doi:10.1371/journal.pone.0074058
   PubMedGoogle Scholar
• Society. CD. Guideline for prevention and treatment of Type 2 diabetes in China; 2017. Available from: http://www.xayxfw.com/uploadfiles/2018/03/201803160832403240.pdf. Accessed October 24, 2019.
   Google Scholar
• Ma W-Y, Yang C-Y, Shih S-R, et al. Measurement of waist circumference: midabdominal or iliac crest? Diabetes Care. 2013;36(6):1660–1666. doi:10.2337/dc12-1452
   PubMed Web of Science ®Google Scholar
• Sun M, Zhang L, Chen S, Liu X, Shao X, Zou H. Association of C-reactive protein and metabolic disorder in a Chinese population. Int J Environ Res Public Health. 2015;12(7):8228–8242. doi:10.3390/ijerph120708228
   PubMedGoogle Scholar
• Liu X, Liu Y, Chen Y, et al. Body mass index (BMI) is associated with microalbuminuria in Chinese hypertensive patients. Int J Environ Res Public Health. 2015;12(2):1998–2008. doi:10.3390/ijerph120201998
   PubMedGoogle Scholar
• Ley SH, Harris SB, Connelly PW, et al. Adipokines and incident type 2 diabetes in an aboriginal Canadian [corrected] population: the sandy lake health and diabetes project. Diabetes Care. 2008;31(7):1410–1415. doi:10.2337/dc08-0036
   PubMed Web of Science ®Google Scholar
• Thorand B, Löwel H, Schneider A, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the monica augsburg cohort study, 1984-1998. Arch Intern Med. 2003;163(1):93–99. doi:10.1001/archinte.163.1.93
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of Type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003;52(7):1799–1805. doi:10.2337/diabetes.52.7.1799
   PubMed Web of Science ®Google Scholar
• Festa A, D’Agostino R, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of Type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002;51(4):1131–1137. doi:10.2337/diabetes.51.4.1131
   PubMed Web of Science ®Google Scholar
• Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol. 2008;108(3–5):272–280. doi:10.1016/j.jsbmb.2007.09.001
   PubMed Web of Science ®Google Scholar
• You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab. 2004;89(11):5517–5522. doi:10.1210/jc.2004-0480
   PubMed Web of Science ®Google Scholar
• Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–574. doi:10.1210/er.2007-0001
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB Jr., Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–438. doi:10.1161/01.CIR.0000111245.75752.C6
   PubMed Web of Science ®Google Scholar